The IGF-I receptor (IGF-IR) may be a promising target for GBM therapy because prior research has shown that GBMs overexpress IGF-IR and insulin-like growth factor receptor II (IGF-IIR) relative to the normal brain (32). Here, IGF1R is linked to glioblastoma.